TuHURA Biosciences, Inc.
HURA
$3.25
$0.3411.68%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | ||
---|---|---|---|---|---|
Net Income | -73.46% | -- | -- | -- | |
Total Depreciation and Amortization | -57.41% | -- | -- | -- | |
Total Amortization of Deferred Charges | -61.34% | -- | -- | -- | |
Total Other Non-Cash Items | 271.17% | -- | -- | -- | |
Change in Net Operating Assets | 700.86% | -- | -- | -- | |
Cash from Operations | -13.88% | -- | -- | -- | |
Capital Expenditure | 8.53% | -- | -- | -- | |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | |
Divestitures | -- | -- | -- | -- | |
Other Investing Activities | -- | -- | -- | -- | |
Cash from Investing | -2,696.59% | -- | -- | -- | |
Total Debt Issued | -100.00% | -- | -- | -- | |
Total Debt Repaid | -- | -- | -- | -- | |
Issuance of Common Stock | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | |
Issuance of Preferred Stock | -- | -- | -- | -- | |
Repurchase of Preferred Stock | -- | -- | -- | -- | |
Total Dividends Paid | -- | -- | -- | -- | |
Other Financing Activities | -176.99% | -- | -- | -- | |
Cash from Financing | -77.14% | -- | -- | -- | |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
Net Change in Cash | -234.16% | -- | -- | -- | |